Central - Tenders Closing for a specific Date

Report For Day : 05-May-2026

Total Tenders : 2210
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
211. 09-Apr-2026 03:41 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM MFT_MED_(PH NO.:08036) CARBAMAZEPINE 400 MG CR TAB/82261336A/107019766 Ministry of Railways --
212. 27-Apr-2026 09:47 AM 05-May-2026 10:30 AM 05-May-2026 10:30 AM HQ_Med_Drugs_ZRC_Zonal Rate Contract for supply of (PH.NO: 65106) Nintedanib 100 mg capsule/tablet/82260898B/107036932 Ministry of Railways --
213. 21-Apr-2026 10:41 AM 05-May-2026 10:30 AM 05-May-2026 10:30 AM HOSE ASSEMBLY, Radiator vent - 1/2 inch ID. x 18 inches long to EMD Part No. 8405061 and to DLW Part No. 17061775 for WDP4/WDG4 Locos ./29263183/107030497 Ministry of Railways --
214. 21-Apr-2026 12:20 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM IOH REPLACEMENT KIT FOR NEW 22CB LOCO Sc/LD251148B/107030742 Ministry of Railways --
215. 25-Mar-2026 02:44 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM HQ_Med_ZRC_Zonal Rate Contract for supply of (PH NO.: 49143) ACITRETIN 25 MG TAB/CAP/82262147A/107005861 Ministry of Railways --
216. 16-Apr-2026 11:58 AM 05-May-2026 10:30 AM 05-May-2026 10:30 AM INTERNAL LOCKING ARRANGEMENT FOR LUGGAGE COMPARTMENT DOORS/04260474/107025704 Ministry of Railways --
217. 25-Mar-2026 02:43 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM HQ_Med_Zonal Rate Contract for supply of (PH No: 51123) Faricimab 6mg/0.05 ml 120 mg/ml intravitreal Injection/82260912A/107005860 Ministry of Railways --
218. 25-Mar-2026 02:45 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM HQ _ Med _(PH NO.:53054) CEFOPERAZONE 1G + SULBACTUM 1G INJECTION/82260672A/107005865 Ministry of Railways --
219. 27-Apr-2026 01:02 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM Set of 09 V-Belts for Screw compressors/L2265338A/107037350 Ministry of Railways --
220. 12-Apr-2026 02:34 PM 05-May-2026 10:30 AM 05-May-2026 10:30 AM RGR-CGR Support Complete/26261497/107022586 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.